Dacatec (Daclatasvir) in combination with peginterferon alfa and ribavirin: The most frequently reported adverse reactions were fatigue, headache, pruritus, anaemia, influenza-like illness, nausea, insomnia, neutropenia, asthenia, rash, decreased appetite, dry skin, alopecia, pyrexia, myalgia, irritability, cough, diarrhoea, dyspnoea and arthralgia.
Dizziness has been reported during treatment with Dacatec (Daclatasvir) in combination with sofosbuvir, and dizziness, disturbance in attention, blurred vision and reduced visual acuity have been reported during treatment with Dacatec (Daclatasvir) in combination with peginterferon alfa and ribavirin.
View ADR Monitoring Form